Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      NephroPlus to open up to 55 dialysis centres by 2018-end

      NephroPlus to open up to 55 dialysis centres by 2018-end

      supriya kashyap kashyap31 Oct 2017 9:35 AM IST
      New Delhi: Dialysis service provider NephroPlus is looking to open up to 55 centres across India by the end of next year as part of its expansion...
      CBI FIR against Sterling Biotech for Rs 5,000 cr loan default

      CBI FIR against Sterling Biotech for Rs 5,000 cr loan default

      supriya kashyap kashyap30 Oct 2017 12:47 PM IST
      New Delhi: The CBI has registered a fresh case against Sterling Biotech Limited, which was under probe for allegedly bribing senior tax officials, for...
      Zydus Nesher Pharma gets USFDA nod to market influenza drug

      Zydus' Nesher Pharma gets USFDA nod to market influenza drug

      supriya kashyap kashyap30 Oct 2017 12:07 PM IST
      New Delhi: Drug firm Zydus Cadila said Nesher Pharmaceuticals, a subsidiary of its US arm, has received final approval from the US health regulator to...
      Eagle Pharma gets tentative FDA approval for Lillys Alimta version

      Eagle Pharma gets tentative FDA approval for Lilly's Alimta version

      supriya kashyap kashyap30 Oct 2017 12:07 PM IST
      Eagle Pharmaceuticals Inc said the U.S. Food and Drug Administration tentatively approved its diluted version of Eli Lilly and Co's blockbuster cancer...
      Sebi imposes Rs 30 lakh fine on Plethico Pharma, 3 others

      Sebi imposes Rs 30 lakh fine on Plethico Pharma, 3 others

      supriya kashyap kashyap30 Oct 2017 12:06 PM IST
      New Delhi: Markets regulator Sebi imposed Rs 30 lakh fine on Plethico Pharmaceuticals and its three senior officials for disclosure lapses and failure...
      Fosun Pharma to buy Frances Tridem for $73 mln

      Fosun Pharma to buy France's Tridem for $73 mln

      supriya kashyap kashyap30 Oct 2017 9:06 AM IST
      Hong Kong: Shanghai Fosun Pharmaceutical (Group) Co Ltd said it would buy French drug distributor Tridem Pharma S.A.S. for 63 million euros ($73...
      AbbVie says Humira sales will balloon to $21 billion in 2020, shares rise

      AbbVie says Humira sales will balloon to $21 billion in 2020, shares rise

      supriya kashyap kashyap29 Oct 2017 9:15 AM IST
      AbbVie Inc (ABBV.N) forecast its flagship drug Humira to bring $21 billion in sales by 2020, about $3 billion higher than its expectation two years...
      Bayer cuts Monsanto deal value to $63.5 billion on revised debt

      Bayer cuts Monsanto deal value to $63.5 billion on revised debt

      supriya kashyap kashyap29 Oct 2017 9:15 AM IST
      FRANKFURT: German drugmaker Bayer has cut the value of its takeover of Monsanto by $2.5 billion, which combined with windfalls from asset sales means...
      Merck swings to 3Q loss on big charge but raises forecast

      Merck swings to 3Q loss on big charge but raises forecast

      supriya kashyap kashyap29 Oct 2017 9:09 AM IST
      Lower sales for multiple medicines and a whopping charge for a big collaboration in cancer drugs drove Merck & Co. to a third-quarter loss of $56...
      Indian-American billionaire charged with leading pharmaceutical fraud scheme in US

      Indian-American billionaire charged with leading pharmaceutical fraud scheme in US

      supriya kashyap kashyap28 Oct 2017 12:17 PM IST
      Washington: An Indian-American pharmaceutical billionaire was today charged with leading a nationwide conspiracy in the US by bribing doctors to over...
      Cipla gets USFDA nod for generic version of Renvela tablets

      Cipla gets USFDA nod for generic version of Renvela tablets

      supriya kashyap kashyap28 Oct 2017 9:18 AM IST
      New Delhi: Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US health regulator for Sevelamer...
      Biocon Q2 net profit down 53 percent at Rs 68.8 cr

      Biocon Q2 net profit down 53 percent at Rs 68.8 cr

      supriya kashyap kashyap28 Oct 2017 9:18 AM IST
      New Delhi: Bio-pharmaceutical firm Biocon reported a 53.10 percent dip in its consolidated net profit to ₹68.8 crore for the quarter ended September,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok